TJRJ Gathers Evidence on Cannabis Use in People with ADHD

In the restless silence of those seeking focus amidst the whirlwind of the mind, a question echoes: could cannabis offer relief for individuals with Attention Deficit Hyperactivity Disorder (ADHD)?

Thinking of comforting those searching for quality of life, the Rio de Janeiro State Court of Justice (TJRJ) has just made available on its Portal of Law and Health a systematic review on the use of cannabis-based medications in the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The study, entitled 'Cannabis Derivatives and Their Synthetic Analogs for Attention Deficit Hyperactivity Disorder,' was developed by the Health Technology Assessment Center and the Evidence Center of Hospital Sírio-Libanês (NATS/NEv-HSL) and published on September 5.

The review aimed to verify if medicinal cannabis could bring benefits to individuals with ADHD, evaluating impacts on symptoms, quality of life, and potential risks. The researchers gathered available information, synthesized the findings, and analyzed the robustness of the data. They checked if the evidence was solid enough to draw conclusions about the benefits and risks of cannabis use.

The full material can be accessed on the Portal of Law and Health, which gathers technical content aimed at supporting judges and court officials in decisions related to public and supplementary healthcare demands.

Read More

Can Cannabis Actually Treat ADHD?

Benefits of Medicinal Cannabis Use in Treating Attention Deficit Hyperactivity Disorder (ADHD)